Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2017.01.055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bile Acid Alterations in Nonalcoholic Fatty Liver Disease, Obesity, Insulin Resistance and Type 2 Diabetes

Current Opinion in Lipidology
NutritionGeneticsCell BiologyMolecular BiologyCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2019English

Fatty Acid Metabolism in Obesity and Type 2 Diabetes Mellitus

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2003English

Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes

Medical Council
2016English

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Hepatology
MedicineHepatology
2014English

Neurotensin and Nonalcoholic Fatty Liver Disease: Beyond Obesity

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

Genetics of Common Obesity and Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2009English

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology
2019English

Decreased Hepatotoxic Bile Acid Composition and Altered Synthesis in Progressive Human Nonalcoholic Fatty Liver Disease

Toxicology and Applied Pharmacology
ToxicologyPharmacology
2013English

Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: Importance of Glycemic Control

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy